Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) — Analysis Summary
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) has a market cap of $1.90M with year-over-year revenue growth of +6.0%. Net margin stands at -965.0%. The stock trades at a P/E ratio of -0.1.
Key Takeaways
- Revenue changed +6.0% year-over-year
- Net margin of -965.0%
- P/E ratio of -0.1
Compared with its sector, BYAH posted revenue growth of +6.0% and trades at a P/E of -0.1.
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -588997.6x — earnings do not cover interest payments
Operating margin at -956.5% — severe operating losses
Net margin at -965.0% — losses exceed revenue (possible one-time charges)
The latest filing shows negative free cash flow.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
Employees
40
Exchange
XNAS
At least 3 years of annual financial data required to assess competitive moat.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.